Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: Results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic urial

Objectives The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI). Background Glycoprotein IIb/IIIa inhibitors enhance thrombolysis. The role of combination therapy in clinical practice remains to be esta...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2003-04, Vol.41 (8), p.1251
Main Author: Giugliano, Robert P
Format: Article
Language:English
Subjects:
Cardiology
Coronary vessels
Drug therapy
Heart attacks
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI). Background Glycoprotein IIb/IIIa inhibitors enhance thrombolysis. The role of combination therapy in clinical practice remains to be established. Methods Patients (n = 438) with STEMI
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(03)00123-2